Conception rate of intrauterine insemination in a subfertile population cervical factor, mild male factor, unexplained infertility in tertiary care centre

Shyamkumar Sirsam; Tanzeela Fatema Khan; Vivek Karale; Ankush Ajmera

doi:10.18203/2320-1770.ijrcog20253899

Authors

Shyamkumar Sirsam Department of Obstetrics and Gynecology, Government Medical College, Akola, Maharashtra, India
Tanzeela Fatema Khan Department of Obstetrics and Gynecology, Government Medical College, Akola, Maharashtra, India
Vivek Karale Department of Obstetrics and Gynecology, Government Medical College, Akola, Maharashtra, India
Ankush Ajmera Department of Obstetrics and Gynecology, Government Medical College, Akola, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20253899

Keywords:

Cervical Factor, Conception rate, Intrauterine insemination, Mild male factor, Subfertility, Unexplained infertility

Abstract

Background: Intrauterine insemination (IUI) is a widely used assisted reproductive technique for subfertile couples, particularly those with cervical factor, mild male factor, or unexplained infertility. Despite its popularity, the effectiveness of IUI across different etiologies remains debated.

Methods: This observational study was conducted at the department of obstetrics and gynecology, Government Medical College and Hospital, Akola, Maharashtra. Subfertile women were categorized based on etiology- cervical factor, mild male factor, or unexplained infertility- and underwent IUI following standard ovulation induction protocols. Primary outcomes included conception rate per cycle and cumulative pregnancy rate. Secondary outcomes assessed endometrial thickness, follicular response, and cycle characteristics.

Results: IUI yielded variable conception rates across etiological groups. Women with cervical factor infertility demonstrated the highest conception rates, followed by those with unexplained infertility and mild male factor. Favourable endometrial thickness and monofollicular development were associated with higher pregnancy rates. The number of cycles required for conception was lowest in the cervical factor group.

Conclusions: IUI remains a cost-effective and minimally invasive first-line treatment for selected subfertile populations. Cervical factor infertility responds most favorably to IUI, while mild male factor and unexplained infertility show moderate success. Careful patient selection and individualized stimulation protocols enhance outcomes.

Metrics

Metrics Loading ...

References

World Health Organization. Infertility prevalence estimates, 2023. Geneva: WHO; 2023.

Zegers-Hochschild F, Adamson GD, De Mouzon J, Ishihara O, Mansour R, Nygren K, et al. The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on ART terminology, 2009. Hum Reprod. 2009;24(11):2683-7. DOI: https://doi.org/10.1093/humrep/dep343

Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9(12):e1001356. DOI: https://doi.org/10.1371/journal.pmed.1001356

Dutta DC. Textbook of Gynecology. 7th ed. New Delhi: Jaypee Brothers Medical Publishers; 2016. DOI: https://doi.org/10.5005/jp/books/12997

Loret de Mola JR. Amenorrhea. ClinicalGate. Available from: http://clinicalgate.com/amenorrhea-2/. Accessed on 4 August 2025.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;19(1):41-7. DOI: https://doi.org/10.1093/humrep/deh098

Cohlen BJ. Should we continue performing intrauterine insemination in the year 2004? Hum Reprod. 2005;20(4):978-84. DOI: https://doi.org/10.1159/000080492

Ombelet W, Dhont N, Thijssen A, Bosmans E, Cox A. Semen quality and intrauterine insemination. Reprod Biomed Online. 2014;28(3):300-9. DOI: https://doi.org/10.1016/j.rbmo.2013.10.023

Bensdorp AJ, Tjon-Kon-Fat R, Verhoeve H, Koks C, Hompes P, Hoek A, et al. Dropout rates in couples undergoing in vitro fertilization and intrauterine insemination. Eur J Obstet Gynecol Reprod Biol. 2016;205:66-71. DOI: https://doi.org/10.1016/j.ejogrb.2016.08.018

Hunter J. Historical account of artificial insemination. Med Hist. 1770;15(2):123-6.

Sherman JK. Cryopreservation of human spermatozoa: a review. Fertil Steril. 1953;4(2):131-47.

Van Rumste MM, Custers IM, van der Veen F, van der Hout L, Evers JL, Mol BW. The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. Hum Reprod Update. 2008;14(6):563-70. DOI: https://doi.org/10.1093/humupd/dmn034

National Institute for Health and Care Excellence (NICE). Fertility: assessment and treatment for people with fertility problems. Clinical guideline CG156. London: NICE; 2013.

Cohlen B, Bijkerk A, Van der Poel S, Ombelet W. IUI: review and systematic assessment of the evidence that supports global recommendations. Hum Reprod Update. 2018;24(3):300-19. DOI: https://doi.org/10.1093/humupd/dmx041

Cohlen BJ, Ombelet W. Intrauterine insemination: evidence-based medicine in 2014. Facts Views Vis ObGyn. 2014;6(3):153-6.

Franik S, Kremer JA, Nelen WL, Farquhar C, Clark J, Van der Veen F. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;4:CD009254. DOI: https://doi.org/10.1002/14651858.CD010287.pub3